The Growing Global Threat Of Antibiotic Resistance Ielts Reading Answers Verified [2021] Jun 2026

Remember: In the real exam, always base your answer only on the text provided, even if your prior knowledge contradicts it. The verified answers above align with Cambridge IELTS standards, but your specific test passage may vary slightly in figures. Focus on synonyms and contextual clues.

Also, here are some IELTS Reading Tips:

The Growing Global Threat of Antibiotic Resistance Comprehensive Reading Passage Paragraph A Remember: In the real exam, always base your

Determine if the following statements agree with the information provided in the reading passage.

(It is often unprofitable, leading to a "dry pipeline" of new drugs). Also, here are some IELTS Reading Tips: The

The phenomenon of antimicrobial resistance (AMR) arises when micro-organisms evolve mechanisms that protect them from the effects of antimicrobials. While mutation is a natural evolutionary process, the speed at which resistance is developing can be directly attributed to the indiscriminate usage of antibiotic agents in both clinical and veterinary settings. Economists predict that if current trends persist unchecked, drug-resistant infections could cause up to 10 million deaths annually by the middle of the century, eclipsing cancer as a leading cause of mortality. Questions 1–5: True, False, or Not Given

For nearly a century, antibiotics have been the cornerstone of modern medicine. From treating strep throat to enabling complex surgeries like organ transplants and chemotherapy, these miracle drugs have saved hundreds of millions of lives. However, the World Health Organization (WHO) has declared one of the top ten global public health threats facing humanity. The phrase "the growing global threat of antibiotic resistance" is not just a headline; it is a clarion call for immediate action. While mutation is a natural evolutionary process, the

from this passage, such as the flow-chart completion or the matching features section?

Given the limited pipeline for new antibiotics, there is a pressing need for innovative research. Organizations like the Global Antibiotic Research and Development Partnership (GARDP) are investing in research and development of new antibiotics and alternative therapies. Collaborative efforts between governments, healthcare institutions, and pharmaceutical companies are crucial to overcome financial and regulatory challenges.